• E. coli vaccine developed

    A Michigan State University researcher has developed a working vaccine for a strain of E. coli that kills 2 million to 3 million children each year in the developing world

  • Hundreds of patients in Illinois exposed to TB

    A medical residents on hospital rotations unknowingly exposes hundreds of patients to TB; o far, no one has tested positive for the disease

  • Ebola lab accident tests experimental vaccine

    A lab scientist in Germany accidentally pricked her finger with a needle carrying Ebola virus; there are no approved vaccines for Ebola, and Ebola accidents have killed lab technicians before; the German technician was given an experimental vaccine, and so far developed no symptoms

  • Smart bandage tells doctors about state of wound healing

    Dutch researchers develop a smart bandage which updates doctors about the wound healing process; bandage made of printed electronic sensors; the researchers’ next goal: add an antenna to transmit information about the patient’s health remotely to the attending physician

  • Predicting population of disease-carrying mosquitoes

    Researchers at University of Adelaide in Australia create a model predicting population peaks of disease-carrying mosquitoes; model will help in developing cost-effective mosquito control policies

  • Human vaccine against bird flu a reality with new discovery

    Aussie researchers added a compound, known to increase immunity, to the flu vaccine in an animal model; the addition of this compound promoted significant generation of potent killer T cell immunity and provided protection from infection

  • Innovative pandemic flu vaccine effective against H5N1 in mice

    The current method of growing seasonal influenza vaccines in chicken eggs is slow and inefficient; Emory University scientists have developed an alternative: virus-like particles, empty shells that look like viruses but do not replicate

  • Houseplant pest offers clues to potential new anthrax treatment

    A humble bacterium with a long name — Pectobacterium chrysanthemi (Dickya dadantii) — attacks, and often kills, the popular African violet, which is found in many urban and suburban back yards; it does so by competing with its host — the violet — for iron; Warwick University researchers find that the bacteria’s chemical pathway could be blocked or inhibited to prevent the bacterium from harvesting iron, essentially starving it; this work has major implications for the treatment of several virulent and even deadly mammalian infections including Anthrax

  • Woman dies of bird flu in Vietnam

    The World Health Organization reports that H5N1 has killed 254 people across the world since 2003; the latest victim is a Vietnamese woman, bringing the death toll from avian flu in Vietnam to 53 since the end of 2003 — the highest in the world

  • Monoclonal antibodies effective against bird flu, seasonal flu

    Worldwide, more than 250,000 deaths from seasonal influenza occur annually; if a breakout of avian flu occurs, the number of deaths is incalculable; scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses

  • China reports bird flu cases in which humans are infected, but not birds

    China’s Ministry of Health said it was puzzled by eight human cases of bird flu in January which appeared independent of any known case in birds; five Chinese died from H5N1 in January in far-flung regions without any reported presence of the virus in birds on the mainland

  • First ever U.S. case of Marburg fever confirmed in Colorado

    Marburg hemorrhagic fever is extremely rare — and deadly; the disease is caused by a virus indigenous to Africa, and was brought to the United States by a researcher who traveled to Uganda

  • Fake Internet drugs risk lives, fund terrorism

    Study finds that 62 percent of the prescription-only medicines offered on the Internet are fakes; some of the fake-drug schemes are operated by terrorist organizations as a means of raising funds

  • Political squabbles hobble H5N1 research

    Indonesia has had the most cases of human H5N1 flu since 2005; it refuses to share the virus samples with Western pharmaceutical companies unless these companies agree to share with Indonesia the profits from the vaccine these companies develop — and also guarantee Indonesia access to a vaccine in case of a pandemic

  • Researchers show promising approach to avian flu vaccine

    Terrapin researchers are developing a universal flu vaccine for animals; it could ultimately help prevent or delay another avian flu pandemic in humans